L. Bodet, P. Gomez-bougie, C. Touzeau, C. Dousset, G. Descamps et al., ABT-737 is highly effective against molecular subgroups of multiple myeloma, Blood, vol.118, issue.14, pp.3901-3910, 2011.
DOI : 10.1182/blood-2010-11-317438

M. Chesi and P. L. Bergsagel, Molecular pathogenesis of multiple myeloma: basic and clinical updates, International Journal of Hematology, vol.97, issue.3, pp.313-323, 2013.
DOI : 10.1007/s12185-013-1291-2

K. Doi, R. Li, S. S. Sung, H. Wu, Y. Liu et al., Discovery of Marinopyrrole A (Maritoclax) as a Selective Mcl-1 Antagonist that Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation, Journal of Biological Chemistry, vol.287, issue.13, pp.10224-10235, 2012.
DOI : 10.1074/jbc.M111.334532

J. M. Eichhorn, S. E. Alford, C. C. Hughes, W. Fenical, and T. C. Chambers, Purported Mcl-1 inhibitor marinopyrrole A fails to show selective cytotoxicity for Mcl-1-dependent cell lines, Cell Death and Disease, vol.4, issue.10, p.880, 2013.
DOI : 10.1074/jbc.M112.391854

P. Gomez-bougie and M. Amiot, Apoptotic Machinery Diversity in Multiple Myeloma Molecular Subtypes, Frontiers in Immunology, vol.4, p.467, 2013.
DOI : 10.3389/fimmu.2013.00467

A. Malina, J. R. Mills, and J. Pelletier, Emerging Therapeutics Targeting mRNA Translation, Cold Spring Harbor Perspectives in Biology, vol.4, issue.4, 2012.
DOI : 10.1101/cshperspect.a012377

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312682

M. K. Pandey, K. Gowda, K. Doi, A. K. Sharma, H. G. Wang et al., Proteasomal Degradation of Mcl-1 by Maritoclax Induces Apoptosis and Enhances the Efficacy of ABT-737 in Melanoma Cells, PLoS ONE, vol.5, issue.11, p.78570, 2013.
DOI : 10.1371/journal.pone.0078570.s001

S. Surget, D. Chiron, P. Gomez-bougie, G. Descamps, E. Menoret et al., Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells, Cancer Research, vol.72, issue.17, pp.4562-4573, 2012.
DOI : 10.1158/0008-5472.CAN-12-0487

S. Varadarajan, P. Poornima, M. Milani, K. Gowda, S. Amin et al., Maritoclax and dinaciclib inhibit MCL-1 activity and induce apoptosis in both a MCL-1-dependent and -independent manner, Oncotarget, vol.6, issue.14, pp.12668-12681, 2015.
DOI : 10.18632/oncotarget.3706

S. N. Willis, L. Chen, G. Dewson, A. Wei, E. Naik et al., Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins, Genes & Development, vol.19, issue.11, pp.1294-1305, 2005.
DOI : 10.1101/gad.1304105

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1142553